U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

FDA regulates only some health app features Since the introduction ... s Science and Educational Media Group and the Robert ...

theorizing that a different trial design could yield better results and pave the way for FDA approval in chronic pain. AP video journalist Mary Conlon contributed to this story from New York.

theorizing that a different trial design could yield better results and pave the way for FDA approval in chronic pain. AP video journalist Mary Conlon contributed to this story from New York.

theorizing that a different trial design could yield better results and pave the way for FDA approval in chronic pain. AP video journalist Mary Conlon contributed to this story from New York.